Inhibrx Reaches Analyst Target Price
December 02, 2020 at 09:12 AM EST
In recent trading, shares of Inhibrx Inc (INBX) have crossed above the average analyst 12-month target price of $29.33, changing hands for $32.68/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..